IFN-β1b induces OAS3 to inhibit EV71 via IFN-β1b/JAK/STAT1 pathway

Virol Sin. 2022 Oct;37(5):676-684. doi: 10.1016/j.virs.2022.07.013. Epub 2022 Aug 5.

Abstract

Enterovirus 71 (EV71) caused hand, foot and mouth disease (HFMD) is a serious threat to the health of young children. Although type I interferon (IFN-I) has been proven to control EV71 replication, the key downstream IFN-stimulated gene (ISG) remains to be clarified and investigated. Recently, we found that 2'-5'-oligoadenylate synthetases 3 (OAS3), as one of ISG of IFN-β1b, was antagonized by EV71 3C protein. Here, we confirm that OAS3 is the major determinant of IFN-β1b-mediated EV71 inhibition, which depends on the downstream constitutive RNase L activation. 2'-5'-oligoadenylate (2-5A) synthesis activity deficient mutations of OAS3 D816A, D818A, D888A, and K950A lost resistance to EV71 because they could not activate downstream RNase L. Further investigation proved that EV71 infection induced OAS3 but not RNase L expression by IFN pathway. Mechanically, EV71 or IFN-β1b-induced phosphorylation of STAT1, but not STAT3, initiated the transcription of OAS3 by directly binding to the OAS3 promoter. Our works elucidate the immune regulatory mechanism of the host OAS3/RNase L system against EV71 replication.

Keywords: 2′-5′-oligoadenylate synthetases 3 (OAS3); Enterovirus 71 (EV71); IFN-β1b; JAK/STAT; RNase L.

MeSH terms

  • 2',5'-Oligoadenylate Synthetase / genetics
  • 2',5'-Oligoadenylate Synthetase / metabolism
  • Adenine Nucleotides
  • Child, Preschool
  • Enterovirus A, Human*
  • Enterovirus* / metabolism
  • Humans
  • Interferon Type I* / genetics
  • Ligases / metabolism
  • Oligoribonucleotides
  • STAT1 Transcription Factor / metabolism

Substances

  • Adenine Nucleotides
  • Interferon Type I
  • Oligoribonucleotides
  • STAT1 Transcription Factor
  • STAT1 protein, human
  • 2',5'-oligoadenylate
  • 2',5'-Oligoadenylate Synthetase
  • OAS3 protein, human
  • Ligases